Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Statins and cancer--beyond the "one drug, one disease" model.

Literature DB >> 15917390

Statins and cancer--beyond the "one drug, one disease" model.

Ernest Hawk, Jaye L Viner.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2005 PMID： 15917390 DOI： 10.1056/NEJMe058074

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

8 in total

Review 1. Optical molecular imaging and its emerging role in colorectal cancer.

Authors: Rahul A Sheth; Umar Mahmood
Journal: Am J Physiol Gastrointest Liver Physiol Date: 2010-07-01 Impact factor: 4.052

2. Statin use and risk of hepatocellular carcinoma in a U.S. population.

Authors: Katherine A McGlynn; George W Divine; Vikrant V Sahasrabuddhe; Lawrence S Engel; Ashley VanSlooten; Karen Wells; Marianne Ulcickas Yood; Sharon Hensley Alford
Journal: Cancer Epidemiol Date: 2014-08-10 Impact factor: 2.984

3. Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins.

Authors: Jean-Pierre H Perchellet; Elisabeth M Perchellet; Kyle R Crow; Keith R Buszek; Neil Brown; Sampathkumar Ellappan; Ge Gao; Diheng Luo; Machiko Minatoya; Gerald H Lushington
Journal: Int J Mol Med Date: 2009-11 Impact factor: 4.101

4. Statin use and the risk of cholecystectomy in women.

Authors: Chung-Jyi Tsai; Michael F Leitzmann; Walter C Willett; Edward L Giovannucci
Journal: Gastroenterology Date: 2009-01-24 Impact factor: 22.682

5. Statins inhibit the growth of variant human embryonic stem cells and cancer cells in vitro but not normal human embryonic stem cells.

Authors: K Gauthaman; N Manasi; A Bongso
Journal: Br J Pharmacol Date: 2009-05-11 Impact factor: 8.739

Statins and cancer--beyond the "one drug, one disease" model.

Review 1. Optical molecular imaging and its emerging role in colorectal cancer.

2. Statin use and risk of hepatocellular carcinoma in a U.S. population.

3. Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins.

4. Statin use and the risk of cholecystectomy in women.

5. Statins inhibit the growth of variant human embryonic stem cells and cancer cells in vitro but not normal human embryonic stem cells.

Review 6. Statins: do they have a potential role in cancer prevention and modifying cancer-related outcomes?

7. Network target for screening synergistic drug combinations with application to traditional Chinese medicine.

8. Cancer risk in older people receiving statin therapy: a meta-analysis of randomized controlled trials.